- Home
- OCEAW vs TBI Comparison
OCEAW vs TBI Comparison
Compare OCEAW & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- TBI
- Stock Information
- Founded
- OCEAW N/A
- TBI 1985
- Country
- OCEAW United States
- TBI United States
- Employees
- OCEAW 7
- TBI N/A
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- TBI Professional Services
- Sector
- OCEAW Health Care
- TBI Consumer Discretionary
- Exchange
- OCEAW Nasdaq
- TBI Nasdaq
- Market Cap
- OCEAW N/A
- TBI N/A
- IPO Year
- OCEAW 2021
- TBI 1996
- Fundamental
- Price
- OCEAW $0.03
- TBI $5.31
- Analyst Decision
- OCEAW
- TBI Buy
- Analyst Count
- OCEAW 0
- TBI 2
- Target Price
- OCEAW N/A
- TBI $11.50
- AVG Volume (30 Days)
- OCEAW N/A
- TBI 227.8K
- Earning Date
- OCEAW N/A
- TBI 05-05-2025
- Dividend Yield
- OCEAW N/A
- TBI N/A
- EPS Growth
- OCEAW N/A
- TBI N/A
- EPS
- OCEAW N/A
- TBI N/A
- Revenue
- OCEAW N/A
- TBI $1,567,393,000.00
- Revenue This Year
- OCEAW N/A
- TBI N/A
- Revenue Next Year
- OCEAW N/A
- TBI $9.22
- P/E Ratio
- OCEAW N/A
- TBI N/A
- Revenue Growth
- OCEAW N/A
- TBI N/A
- 52 Week Low
- OCEAW N/A
- TBI $5.19
- 52 Week High
- OCEAW N/A
- TBI $12.52
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- TBI 38.11
- Support Level
- OCEAW N/A
- TBI $5.53
- Resistance Level
- OCEAW N/A
- TBI $5.92
- Average True Range (ATR)
- OCEAW 0.00
- TBI 0.27
- MACD
- OCEAW 0.00
- TBI 0.05
- Stochastic Oscillator
- OCEAW 0.00
- TBI 11.88
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.